BIMI International Medical(BIMI)
$0.000.00 (0.00%)
BIMI
BIMI International Medical financials statements
$0.00
At close:0.00 (0.00%)
BIMI International Medical (BIMI) Ratios
230 Followers
BIMI International Medical Ratios
BIMI's free cash flow for Q2 2023 was $-570.38K. For the 2023 fiscal year, BIMI's free cash flow was decreased by $-5.00 and operating cash flow was $-570.38K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Mar 22 | Mar 21 | Mar 20 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.92 | 0.96 | 1.62 | 1.02 | 0.20 |
| Quick Ratio | 0.61 | 0.72 | 1.57 | 0.99 | 0.13 |
| Cash Ratio | 0.09 | 0.22 | 0.01 | 0.00 | 0.00 |
| Solvency Ratio | -0.73 | -1.30 | -0.32 | -0.19 | -1.21 |
| Operating Cash Flow Ratio | -0.40 | -0.06 | -0.23 | -0.10 | -0.03 |
| Short-Term Operating Cash Flow Coverage | -5.04 | -0.20 | -0.82 | -19.23 | -0.06 |
| Net Current Asset Value | $ -7.26M | $ -5.63M | $ 8.88M | $ 500.76K | $ -10.46M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.23 | 0.15 | 0.00 | 0.25 |
| Debt-to-Equity Ratio | 1.35 | 0.78 | 0.30 | 0.01 | 0.57 |
| Debt-to-Capital Ratio | 0.57 | 0.44 | 0.23 | 0.01 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.05 | 0.04 | 0.00 | 0.00 |
| Financial Leverage Ratio | 8.82 | 3.41 | 1.99 | 3.46 | 2.27 |
| Debt Service Coverage Ratio | -3.29 | -3.64 | -0.84 | -11.15 | -2.49 |
| Interest Coverage Ratio | -4.47 | -3.32 | -44.89 | -155.35 | -37.93 |
| Debt to Market Cap | 7.16 | 5.04 | 2.81 | 0.04 | 0.49 |
| Interest Debt Per Share | 3.33 | 20.84 | 23.98 | 0.70 | 41.68 |
| Net Debt to EBITDA | -0.17 | -0.12 | -1.53 | -0.06 | -0.37 |
| Profitability Margins | |||||
| Gross Profit Margin | 16.48% | 11.38% | 19.02% | -92.42% | 7.02% |
| EBIT Margin | -153.77% | -151.13% | -25.43% | -968.49% | -247.13% |
| EBITDA Margin | -151.88% | -149.99% | -25.00% | -802.65% | -237.60% |
| Operating Profit Margin | -129.65% | -38.03% | -29.68% | -624.14% | -241.42% |
| Pretax Profit Margin | -182.77% | -162.59% | -26.10% | -972.29% | -256.53% |
| Net Profit Margin | -189.29% | -164.10% | -41.21% | -2809.88% | -256.60% |
| Continuous Operations Profit Margin | -182.82% | -162.73% | -29.47% | -972.29% | -256.60% |
| Net Income Per EBT | 103.57% | 100.93% | 157.92% | 289.00% | 100.03% |
| EBT Per EBIT | 140.97% | 427.58% | 87.93% | 155.78% | 106.26% |
| Return on Assets (ROA) | -62.70% | -91.76% | -15.94% | -14.77% | -72.83% |
| Return on Equity (ROE) | -553.23% | -312.56% | -31.68% | -51.13% | -165.62% |
| Return on Capital Employed (ROCE) | -148.16% | -50.55% | -21.61% | -11.58% | -158.17% |
| Return on Invested Capital (ROIC) | -118.73% | -35.51% | -17.39% | -11.44% | -99.95% |
| Return on Tangible Assets | -66.58% | -117.66% | -20.14% | -20.10% | -72.83% |
| Earnings Yield | -6831.40% | -2558.30% | -296.99% | -170.34% | -142.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.83 | 3.51 | 1.54 | 15.65 | 4.88 |
| Payables Turnover | 0.92 | 3.63 | 1.78 | 0.00 | 0.00 |
| Inventory Turnover | 1.29 | 3.67 | 14.15 | 0.43 | 6.49 |
| Fixed Asset Turnover | 2.55 | 2.55 | 14.11 | 4.09 | 0.32 |
| Asset Turnover | 0.33 | 0.56 | 0.39 | 0.01 | 0.28 |
| Working Capital Turnover Ratio | -7.73 | 4.91 | 2.54 | -0.03 | -2.24 |
| Cash Conversion Cycle | 13.14 | 102.93 | 57.43 | 872.49 | 131.07 |
| Days of Sales Outstanding | 128.82 | 103.99 | 236.97 | 23.32 | 74.79 |
| Days of Inventory Outstanding | 282.77 | 99.45 | 25.80 | 849.16 | 56.28 |
| Days of Payables Outstanding | 398.45 | 100.51 | 205.34 | 0.00 | 0.00 |
| Operating Cycle | 411.59 | 203.44 | 262.78 | 872.49 | 131.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.85 | -2.38 | -16.48 | -12.64 | -2.30 |
| Free Cash Flow Per Share | -3.85 | -3.90 | -17.69 | -12.64 | -2.30 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1.57 | -13.58 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | -1.57 | -13.58 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.88 | -0.15 | -0.70 | -19.23 | -0.06 |
| Operating Cash Flow to Sales Ratio | -0.87 | -0.06 | -0.27 | -13.07 | -0.05 |
| Free Cash Flow Yield | -3128.54% | -152.86% | -211.89% | -79.23% | -2.92% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.01 | -0.04 | -0.34 | -0.59 | -0.70 |
| Price-to-Sales (P/S) Ratio | 0.03 | 0.06 | 0.14 | 16.50 | 1.80 |
| Price-to-Book (P/B) Ratio | 0.08 | 0.12 | 0.11 | 0.30 | 1.16 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.03 | -0.65 | -0.47 | -1.26 | -34.19 |
| Price-to-Operating Cash Flow Ratio | -0.03 | -1.07 | -0.51 | -1.26 | -34.19 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 0.03 | 0.01 | -0.00 |
| Enterprise Value Multiple | -0.19 | -0.17 | -2.08 | -2.11 | -1.13 |
| Enterprise Value | 3.45M | 5.30M | 6.68M | 2.68M | 17.56M |
| EV to EBITDA | -0.19 | -0.17 | -2.08 | -2.11 | -1.13 |
| EV to Sales | 0.29 | 0.25 | 0.52 | 16.95 | 2.68 |
| EV to Free Cash Flow | -0.34 | -2.54 | -1.77 | -1.30 | -51.05 |
| EV to Operating Cash Flow | -0.34 | -4.16 | -1.90 | -1.30 | -51.05 |
| Tangible Book Value Per Share | 1.18 | 5.49 | 46.75 | 3.30 | 66.77 |
| Shareholders’ Equity Per Share | 1.52 | 20.87 | 78.29 | 53.14 | 67.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.13 | 0.00 | -0.00 |
| Revenue Per Share | 4.44 | 39.75 | 60.18 | 0.97 | 43.75 |
| Net Income Per Share | -8.40 | -65.24 | -24.80 | -27.17 | -112.25 |
| Tax Burden | 1.04 | 1.01 | 1.58 | 2.89 | 1.00 |
| Interest Burden | 1.19 | 1.08 | 1.03 | 1.00 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| SG&A to Revenue | 0.90 | 0.28 | 0.43 | 6.24 | 2.46 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.46 | 0.04 | 0.93 | 0.91 | 0.02 |
Currency in USD
